Journal
CLINICAL INFECTIOUS DISEASES
Volume 50, Issue 5, Pages E30-E33Publisher
UNIV CHICAGO PRESS
DOI: 10.1086/650488
Keywords
-
Categories
Ask authors/readers for more resources
This study assessed the effect of a 3-month course of pegylated interferon-alpha-2a (Peg-IFN-alpha-2a) in 3 liver transplant patients with chronic active hepatitis E. A virological response was sustained for 6 and 5 months in 2 patients after Peg-IFN-alpha-2a therapy was completed. A relapse was observed in the third patient.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
